Trade name (manufacturer) | Presentations | Age indication | Route |
IIV4s: Inactivated influenza vaccines | |||
Standard-dose, egg-based¶ vaccines | |||
Afluria Quadrivalent (Seqirus) | 0.25-mL PFSΔ | 6 through 35 monthsΔ | IM◊ |
0.5-mL PFSΔ | ≥3 yearsΔ | IM◊ | |
5.0-mL MDVΔ | ≥6 monthsΔ (needle/syringe) 18 through 64 years (jet injector) | IM◊ | |
Fluarix Quadrivalent (GlaxoSmithKline) | 0.5-mL PFS | ≥6 months | IM◊ |
FluLaval Quadrivalent (GlaxoSmithKline) | 0.5-mL PFS | ≥6 months | IM◊ |
Fluzone Quadrivalent (Sanofi Pasteur) | 0.5-mL PFS§ | ≥6 months§ | IM◊ |
0.5-mL SDV§ | ≥6 months§ | IM◊ | |
5.0-mL MDV§ | ≥6 months§ | IM◊ | |
Standard-dose, cell culture-based vaccine (ccIIV4) | |||
Flucelvax Quadrivalent (Seqirus) | 0.5-mL PFS | ≥6 months | IM◊ |
5.0-mL MDV | ≥6 months | IM◊ | |
High-dose, egg-based¶ vaccine (HD-IIV4) | |||
Fluzone High-Dose Quadrivalent (Sanofi Pasteur) | 0.7-mL PFS | ≥65 years | IM◊ |
Standard-dose, egg-based¶ vaccine with MF59 adjuvant (aIIV4) | |||
Fluad Quadrivalent (Seqirus) | 0.5-mL PFS | ≥65 years | IM◊ |
RIV4 (recombinant HA vaccine) | |||
Flublok Quadrivalent (Sanofi Pasteur) | 0.5-mL PFS | ≥18 years | IM◊ |
LAIV4 (live attenuated egg-based vaccine¶) | |||
FluMist Quadrivalent (AstraZeneca) | 0.2-mL prefilled single-use intranasal sprayer | 2 through 49 years | NAS |